Effectiveness of the Single-Dose Ad26.COV2.S COVID Vaccine

in: bioRxiv.org | 2024

by Polinski, J. | Weckstein, A. | Batech, M. | +7

Platelet polyphosphate and SARS-Cov-2 mRNA-vaccine-induced inflammatory side effects: a pilot study

in: bioRxiv.org | 2024

by Uematsu, T. | Sato, A. | Aizawa, H. | +7

Persistent oxidative stress and inflammasome activation in CD14^highCD16^-monocytes from COVID-19 patients

in: bioRxiv.org | 2024

by Lage, S. | Amaral, E. | Hilligan, K. | +15

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

in: bioRxiv.org | 2024

by Lederer, K. | Parvathaneni, K. | Painter, M. | +23

Dynamics of mask use as a prevention strategy against SARS-Cov-2 in Panama

in: bioRxiv.org | 2024

by Fernández-Marín, H. | Bruner-Montero, G. | Portugal-Loayza, A. | +9

Alterations in CD39/CD73 Axis of T cells associated with COVID-19 severity

in: bioRxiv.org | 2024

by Dorneles, G. | Teixeira, P. | da Silva, I. | +12

The impact of heating, ventilation, and air conditioning design features on the transmission of viruses, including the 2019 novel coronavirus: a systematic review of filtration

in: bioRxiv.org | 2024

by Thornton, G. | Fleck, B. | Kroeker, E. | +4

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis

in: bioRxiv.org | 2024

by Baker, D. | MacDougall, A. | Kang, A. | +3

Platelet proteome analysis reveals an early hyperactive phenotype in SARS-CoV-2-infected humanized ACE2 mice

in: bioRxiv.org | 2024

by Subramaniam, S. | Hekman, R. | Jayaraman, A. | +10

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

in: bioRxiv.org | 2024

by Ying, B. | Whitener, B. | VanBlargan, L. | +17